Dr. Tandaw SamdarshiJackson Free PressBased on the pilot, last summer, Samdarshi received a four-year, $3.8 million grant from the National Heart, Lung and Blood Institute to fund the full study. Sleep is a major activity of our lives. If we live to be…
Hoopla over hookah lounge proposal in Bridgewater – Taunton Daily Gazette
Hoopla over hookah lounge proposal in BridgewaterTaunton Daily GazetteCouncilor William Wood, who made the motion to table the ordinance, told his fellow councilors his brother-in-law died of lung cancer. Wood has been raising money for the Jimmy Fund …
Herald Angel has heart transplant
Craig Moseley’s new heart is working well after the Roanoke Rapids resident received a transplant Saturday.
Mass. Eye and Ear ophthalmologist receives Senior Scientific Investigator Award – Phys.Org (press release)
|
Mass. Eye and Ear ophthalmologist receives Senior Scientific Investigator Award
Phys.Org (press release) “I am delighted to have received this support from RPB, which will aid us tremendously in our investigations of ocular surface inflammation in eyes deemed at high risk of corneal transplant rejection,” said Dr. Dana. “With this support, we will be able … |
Organ donation facts and stats – Derbyshire Times
|
Organ donation facts and stats
Derbyshire Times More than 19million people have joined the NHS Organ Donor Register to date, to join them, visit www.organdonation.nhs.uk. Alternatively, you can call the NHS Donor Line on 0300 123 23 23 or text ‘SAVE’ to 84118. Email to a friend; Print this page … |
IncellDx Presents First Study Using Their Novel OncoBreast 3Dx‚Ñ¢ Breast … – PharmiWeb.com (press release)
|
IncellDx Presents First Study Using Their Novel OncoBreast 3Dx‚Ñ¢ Breast …
PharmiWeb.com (press release) About IncellDx, Inc. IncellDx, Inc. is a molecular diagnostics company dedicated to the detection and monitoring of life threatening diseases such as cervical cancer, breast cancer, HIV/AIDs, hepatitis, and organ transplant rejection. For more … |
IncellDx Presents First Study Using Their Novel OncoBreast 3Dx™ Breast … – The Herald | HeraldOnline.com
|
IncellDx Presents First Study Using Their Novel OncoBreast 3Dx™ Breast …
The Herald | HeraldOnline.com … 3Dx platform,” he added. About IncellDx, Inc. IncellDx, Inc. is a molecular diagnostics company dedicated to the detection and monitoring of life threatening diseases such as cervical cancer, breast cancer, HIV/AIDs, hepatitis, and organ transplant … |
Stem Cell Transplant Treats Retinitis Pigmentosa in Mice, Restores Sight – DailyTech
DailyTechStem Cell Transplant Treats Retinitis Pigmentosa in Mice, Restores SightDailyTechScience Stem Cell Transplant Treats Retinitis Pigmentosa in Mice, Restores Sight · Tiffany Kaiser – January 8, 2013 10:06 AM. Print, 1 comment(s) – last by…
IncellDx Presents First Study Using Their Novel OncoBreast 3Dx™ Breast Cancer Technology
IncellDx scientists presented data using IncellDx’s proprietary OncoBreast 3Dx™ technology to multiplex protein markers for tumor type and ER status, markers for her-2 neu protein and mRNA as well as DNA cell cycle and ploidy, all in intact tumor cells in suspension.
Drug dealer walks free from court to save brother's life
A DRUG dealer who faced prison for his third offence in two years has walked free – so he can save his brother’s life.